Skip to content

The Eggs and actiVity in hEalth agiNg Pilot (EVEN-P) Trial in Older Persons

Eggs as Nutrient-Rich Source of Protein to Enhance Activity-Related Health in Older Persons: The Eggs and actiVity in hEalth agiNg Pilot (EVEN-P) Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04264013
Acronym
EVEN-P
Enrollment
0
Registered
2020-02-11
Start date
2020-05-01
Completion date
2021-05-01
Last updated
2023-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

Muscle, Diet, Sarcopenia, Vascular health

Brief summary

Two of the most effective lifestyle-based approaches to reduce the risk of adverse health events and enhance quality of life with aging are exercise and a healthy diet. Currently, the Canadian recommended dietary allowance (RDA) for protein is 0.8 g/kg/day, however, several expert groups have advocated for a higher RDA of protein (\ 1.2 g/kg/day), along with more evenly distributed daily consumption, in older persons. Eggs are considered a nutrient-rich protein source but have recently been scrutinized. This study will compare a high-protein, egg-containing diet and a high-protein, non-egg diet in healthy older persons.

Detailed description

This study will examine the impacts of an egg-containing diet and a non-egg diet in healthy older persons. Briefly, participants (healthy persons, age 60-75 years old) will consume their normal diet or their normal diet plus 4 eggs completing a structured exercise program (designed to meet Canada's Physical Activity Guidelines) for a total of 12 weeks. Participants will be randomly assigned to the Egg or Control (non-egg) group. Before and after the 12-week intervention, participants' undergo assessments of diet-quality, muscle health, fitness, bone health, and vascular health.

Interventions

BEHAVIORALExercise

Participants will exercise in a supervised facility twice weekly and consume their habitual diet.

BEHAVIORALExercise plus diet (egg)

Participants will exercise in a supervised facility twice weekly and consume an addiitonal 4 eggs per day.

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The study will be a randomized parallel-group trial

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
Yes

Exclusion criteria

1. Use assistive walking devices (e.g. cane or walker) 2. Consume any analgesic (pain-relieving) or anti-inflammatory drug(s), prescription or non-prescription, chronically 3. A history of neuromuscular problems or muscle-wasting diseases 4. Any acute chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin or non-insulin dependent diabetes or other metabolic disorders- all ascertained through medical screening questionnaires 5. Chronic consumption of statins (particularly simvastatin/Zocor and atorvastatin/Lipitor) used to lower cholesterol 6. Be on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription-strength acne medications) 7. Have allergies or are not willing to consume eggs 8. Consume a vegetarian diet 9. Had significant weight gain or loss in the past 6 months 10. Have injuries preventing the safe completion of the exercise

Design outcomes

Primary

MeasureTime frameDescription
Dietary protein intake.Pre- and post-intervention over 12 weeksDietary protein intake (specifically meal-to-meal distribution) will be measured in all participants using a 3-day food log.

Secondary

MeasureTime frameDescription
Change in lean massPre- and post-intervention over 12 weeksComposition by DXA
StrengthPre- and post-intervention over 12 weeksHandgrip strength
Vascular healthPre- and post-intervention over 12 weeksMeasures of arterial compliance
Change in body fat massPre- and post-intervention over 12 weeksComposition by DXA

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026